Follow
Sajjad Ahrari
Sajjad Ahrari
Verified email at umontreal.ca
Title
Cited by
Cited by
Year
Comparison of zn, cu, and fe content in hair and serum in alopecia areata patients with normal group
L Dastgheib, Z Mostafavi-Pour, AA Abdorazagh, Z Khoshdel, MS Sadati, ...
Dermatology research and practice 2014, 2014
362014
Comparison of intradermal injection of autologous epidermal cell suspension vs. spraying of these cells on dermabraded surface of skin of patients with post-burn hypopigmentation
A Iman, MA Akbar, KM Mohsen, F Ali, A Armin, A Sajjad, M Ahmad, ...
Indian journal of dermatology 58 (3), 240, 2013
282013
Adipose tissue derived multipotent mesenchymal stromal cells can be isolated using serum-free media
I Ahrari, NP Zarandi, MK Maharlooei, A Monabati, A Attari, S Ahrari
Iranian Red Crescent Medical Journal 15 (4), 324, 2013
272013
Incidence of breast cancer in Fars province, southern Iran: A hospital-based study
D Mehrabani, A Almasi, M Farahmand, Z Ahrari, A Rezaianzadeh, ...
World journal of plastic surgery 1 (1), 16, 2012
202012
Application of molecular dynamics simulations to design a dual-purpose oligopeptide linker sequence for fusion proteins
E Rezaie, M Mohammadi, A Sakhteman, P Bemani, S Ahrari
Journal of Molecular Modeling 24, 1-8, 2018
152018
Interconversion of inactive to active conformation of MARK2: Insights from molecular modeling and molecular dynamics simulation
S Ahrari, N Mogharrab, L Navapour
Archives of biochemistry and biophysics 630, 66-80, 2017
122017
Structure and dynamics of inactive and active MARK4: conformational switching through the activation process
S Ahrari, N Mogharrab, L Navapour
Journal of Biomolecular Structure and Dynamics 38 (8), 2468-2481, 2020
92020
CCR4 C1014T and CCL22 C16A genetic variations in the Iranian patients with colorectal adenocarcinoma
N Erfani, S Ahrari, I Ahrari, SV Hosseini
Iranian Journal of Allergy, Asthma and Immunology, 440-446?, 2014
82014
Disulfide bridge formation to increase thermostability of DFPase enzyme: A computational study
M Mohammadi, A Sakhteman, S Ahrari, K Hassanpour, SE Hashemi, ...
Computational Biology and Chemistry 77, 272-278, 2018
72018
Rational design and engineering of a mutant variant of urate oxidase as a therapeutic enzyme: a molecular dynamics simulation approach
S Ahrari, F Dabbagh, S Ahrari, Y Ghasemi, N Mogharrab, ...
Current Computer-Aided Drug Design 13 (1), 30-38, 2017
52017
Binding analysis of the curcumin-based synthetic alpha-glucosidase inhibitors to beta-lactoglobulin as potential vehicle carrier for antidiabetic drugs
A Yousefi, S Ahrari, F Panahi, Y Ghasemi, R Yousefi
Journal of the Iranian Chemical Society, 1-15, 2022
42022
MARK4 protein can explore the active-like conformations in its non-phosphorylated state
S Ahrari, F Khosravi, A Osouli, A Sakhteman, A Nematollahi, Y Ghasemi, ...
Scientific Reports 9 (1), 12967, 2019
42019
Effects of T208E activating mutation on MARK2 protein structure and dynamics: Modeling and simulation
S Ahrari, N Mogharrab
Molecular biology research communications 3 (3), 149, 2014
42014
p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics
A Ahmadi, S Ahrari, J Salimian, Z Salehi, M Karimi, A Emamvirdizadeh, ...
Cell Communication and Signaling 21 (1), 314, 2023
32023
Ion behavior in the selectivity filter of HCN1 channels
S Ahrari, TN Ozturk, N D'Avanzo
Biophysical Journal 121 (11), 2206-2218, 2022
32022
Ion Behaviour in the HCN1 Channel Selectivity Filter
S Ahrari, N D'Avanzo
Biophysical Journal 118 (3), 265a, 2020
12020
Maltase-glucoamylase inhibition potency and cytotoxicity of pyrimidine-fused compounds: An in silico and in vitro approach
MH Mehraban, M Mansourian, S Ahrari, A HajiEbrahimi, S Odooli, ...
Computational Biology and Chemistry 82, 25-36, 2019
12019
Pharmacological Chaperones: Therapeutic Potential for Diseases Resulting from GPCR Misfolding
SA Laurin, S Ahrari, M Bouvier
Protein Homeostasis in Drug Discovery: A Chemical Biology Perspective, 65-134, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–18